Skip to main content
Advertisement
Advertisement

EVMN

EVMN logo

Evommune, Inc.

9.65
USD
Sponsored
+0.28
+2.99%
Sep 18, 15:59 UTC -4
Closed
exchange

After-Market

9.65

0.00
+0.05%

EVMN Earnings Reports

Positive Surprise Ratio

EVMN beat 1 of 3 last estimates.

33%

Next Report

Date of Next Report
Dec 09, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/
-$0.84
Implied change from Q2 26 (Revenue/ EPS)
--
/
-5.62%
Implied change from Q3 25 (Revenue/ EPS)
--
/
--

Evommune, Inc. earnings per share and revenue

On Aug 06, 2026, EVMN reported earnings of -0.89 USD per share (EPS) for Q2 26, missing the estimate of -0.68 USD, resulting in a -30.61% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +5.23% price change (close before vs. close after earnings).
Looking ahead to Q3 26, -- analysts forecast an EPS of -0.84 USD, with revenue projected to reach -- USD, implying an decrease of -5.62% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
enGene Therapeutics Inc. Common Stock
Report Date
Sep 08, 2026 For Q3 26
Estimate
-$0.43
Actual
-$0.47
Surprise
-7.16%
logo
Anixa Biosciences, Inc.
Report Date
Sep 09, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+8.78%
logo
Alzamend Neuro, Inc. Common Stock
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.57
Actual
-$0.68
Surprise
-19.05%
FAQ
For Q2 2026, Evommune, Inc. reported EPS of -$0.89, missing estimates by -30.61%, and revenue of $0.00, 0% as expectations.
The stock price moved up 5.23%, changed from $13.38 before the earnings release to $14.08 the day after.
The next earning report is scheduled for Dec 09, 2026.
Based on -- analysts, Evommune, Inc. is expected to report EPS of -$0.84 and revenue of -- for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement